News Daiichi Sankyo’s pexidartinib is first FDA-approved drug for... /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0;
R&D On digital twins in rare disease research, with Piet van der... Piet van der Graaf, Senior VP at Certara discusses the potential of digital twins in rare diseases research.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.